Page last updated: 2024-12-06

viridicatin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Viridicatin is a secondary metabolite produced by various fungi, including Penicillium, Aspergillus, and Trichoderma species. It exhibits a range of biological activities, including antibacterial, antifungal, antiparasitic, and cytotoxic effects. The compound's biosynthesis involves a complex pathway that includes polyketide synthase and non-ribosomal peptide synthetase enzymes. Viridicatin has been studied extensively due to its potential as a therapeutic agent for various diseases, particularly infections and cancer. Its unique structure and biological activities make it a valuable target for drug discovery and development. Researchers are actively exploring new synthetic routes to produce viridicatin analogs with improved pharmacological properties.'

viridicatin: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

viridicatin : A hydroxyquinolone that is 3-hydroxyuinolin-2(1H)-one which is substituted at position 4 by a phenyl groups. Isolated from the mycelium of several Penicillium species, it exhibits strong antibiotic activity against M. tuberculosis and also against B. subtilis, S. aureus and S. cerevisiae. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID67206
CHEMBL ID2386742
CHEBI ID140443
SCHEMBL ID5396117
MeSH IDM0054557

Synonyms (30)

Synonym
3-hydroxy-4-phenyl-1h-quinolin-2-one
viridicatin
3-hydroxy-4-phenyl-2(1h)-quinolinone
129-24-8
nsc656625
nsc-656625
ACON0_001468
CHEBI:140443
3-hydroxy-4-phenylcarbostyril
3-hydroxy-4-phenylquinolin-2(1h)-one
2,3-dihydroxy-4-phenylquinoline
unii-45493ks618
45493ks618 ,
CHEMBL2386742
viridicatin [mi]
SCHEMBL5396117
DTXSID10156022
J-005662
QSRVMXWVVMILDI-UHFFFAOYSA-N
4-phenyl-3-hydroxyquinolin-2(1h)-one
3-hydroxy-4-phenyl-1,2-dihydroquinolin-2-one
us9701638, 13
bdbm247022
Q27258806
3-hydroxy-4-phenyl-1h-chinolin-2-one
nsc-794084
nsc794084
HY-125060
CS-0089225
AKOS040756366

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (4)

RoleDescription
antibacterial agentA substance (or active part thereof) that kills or slows the growth of bacteria.
Penicillium metaboliteAny fungal metabolite produced during a metabolic reaction in Penicillium.
marine metaboliteAny metabolite produced during a metabolic reaction in marine macro- and microorganisms.
Aspergillus metaboliteAny fungal metabolite produced during a metabolic reaction in the mould, Aspergillus.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
hydroxyquinoline
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1894490Antibacterial activity against Vibrio anguillarum by microtiter plate method2021Journal of natural products, 03-26, Volume: 84, Issue:3
Freshwater Fungi as a Source of Chemical Diversity: A Review.
AID1894489Antibacterial activity against Bacillus cereus by microtiter plate method2021Journal of natural products, 03-26, Volume: 84, Issue:3
Freshwater Fungi as a Source of Chemical Diversity: A Review.
AID1666597Induction of DNA damage in human SU8686 cells assessed as increase in gammaH2AX phosphorylation at ser193 at cytotoxic IC50 in presence of 0.3 uM doxorubicin by fluorometry method2020Bioorganic & medicinal chemistry, 02-15, Volume: 28, Issue:4
Targeting the DNA damage response (DDR) by natural compounds.
AID1894491Antibacterial activity against Vibrio parahaemolyticus by microtiter plate method2021Journal of natural products, 03-26, Volume: 84, Issue:3
Freshwater Fungi as a Source of Chemical Diversity: A Review.
AID748668Inhibition of H1N1 Influenza A endonuclease after 1 hr by fluorescence assay2013ACS medicinal chemistry letters, Jun-13, Volume: 4, Issue:6
3-Hydroxyquinolin-2(1H)-ones As Inhibitors of Influenza A Endonuclease.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (13.33)18.7374
1990's3 (20.00)18.2507
2000's1 (6.67)29.6817
2010's6 (40.00)24.3611
2020's3 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.93

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.93 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index5.46 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.93)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (18.75%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (81.25%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]